BackGujarat Themis Biosyn Limited Overview

Gujarat Themis Biosyn Limited Receivables

Latest receivables for GUJTHEM.NS: $610M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$609.23M
↑ 93.71% YoYΔ $294.72M vs prior year quarter

Peer trimmed avg / median

Loading

Gujarat Themis Biosyn Limited Receivables History

Loading

Gujarat Themis Biosyn Limited vs. peers: Receivables Comparison

Loading

Gujarat Themis Biosyn Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Gujarat Themis Biosyn Limited (GUJTHEM.NS) FAQ

As of the most recent data (March 2026), GUJTHEM.NS shows a receivables of $610M. That compares with $310M in the prior-year period — up 93.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GUJTHEM.NS's receivables is now $610M (was $310M) — a 93.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Gujarat Themis Biosyn Limited is outperforming or lagging.

Tracking GUJTHEM.NS's receivables over time shows whether Gujarat Themis Biosyn Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $610M That compares with $310M in the prior-year period — up 93.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Gujarat Themis Biosyn Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $610M) with ownership activity and broader fundamentals.